News Select Year All Years 2026 (21) 2025 (37) 2024 (31) 2023 (31) 2022 (35) 2021 (28) 2020 (36) 2019 (46) 2018 (51) 2017 (34) 2016 (26) 2015 (42) 2014 (30) 2013 (26) 2012 (23) 2011 (28) 2010 (36) 2009 (39) 2008 (55) 2007 (50) Clinical Trials Select Clinical Trial AWARE-1 (21) BRACELET-1 (10) GOBLET (35) Search … May 9, 2008 Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial May 5, 2008 Oncolytics Biotech Inc. Announces Details of 2008 Annual Shareholder Meeting March 18, 2008 Oncolytics Biotech Inc. Announces Issuance of 26th U.S. Patent March 17, 2008 Oncolytics Biotech Inc. Announces Publication of Research on Immune Response to REOLYSIN(R) during a Phase I Clinical Trial March 13, 2008 Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at AACR Annual Meeting March 10, 2008 Media Advisory – Oncolytics Biotech Inc. to Present at BioSquare 2008 March 6, 2008 Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 February 21, 2008 Media Advisory – Oncolytics Biotech Inc. to Present at Oncology Biologics Development Primer February 6, 2008 Media Advisory – Oncolytics Biotech Inc. to Present at Bio CEO & Investor Conference February 4, 2008 Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy Newer Page 65 of 71 Older